Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles
Authors:
- 2 October 2016
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 57 (Supplement) , 105S-110S
Abstract
Over the last 2 decades, the use of nanoparticle imaging has been investigated extensively for both diagnosis and therapy of prostate cancer. This review discusses the various classes of nanoparticles currently in clinical use or at the advanced preclinical stage. In particular, we focus on the unique properties of nanoparticles, as a group, that make them suitable for imaging and therapy. The characteristics of each nanoparticle are detailed. Iron oxide nanoparticles, extensively used for MRI of prostate cancer, are discussed in depth.Keywords
This publication has 70 references indexed in Scilit:
- NanomedicineNew England Journal of Medicine, 2010
- Targeting nanoparticles to cancerPharmacological Research, 2010
- Multimodality Imaging Probes: Design and ChallengesChemical Reviews, 2010
- Multifunctional magnetic nanoparticles for targeted imaging and therapy☆Advanced Drug Delivery Reviews, 2008
- Pharmacokinetics and Biodistribution of NanoparticlesMolecular Pharmaceutics, 2008
- Drug delivery and nanoparticles: Applications and hazardsInternational Journal of Nanomedicine, 2008
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Nanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews, 2004
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994